These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 2828443)
1. Prospects for vaccines for herpes simplex viruses. Berman PW J Am Acad Dermatol; 1988 Jan; 18(1 Pt 2):226-30. PubMed ID: 2828443 [TBL] [Abstract][Full Text] [Related]
2. Yeast-derived glycoprotein B-1 of herpes simplex virus (HSV) as a candidate for an HSV vaccine. Kino Y Adv Exp Med Biol; 1990; 278():183-90. PubMed ID: 1963033 [No Abstract] [Full Text] [Related]
3. Protective immunization of mice with specific HSV-1 glycoproteins. Chan WL Immunology; 1983 Jun; 49(2):343-52. PubMed ID: 6303950 [TBL] [Abstract][Full Text] [Related]
4. A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens. Awasthi S; Mahairas GG; Shaw CE; Huang ML; Koelle DM; Posavad C; Corey L; Friedman HM J Virol; 2015 Aug; 89(16):8497-509. PubMed ID: 26041292 [TBL] [Abstract][Full Text] [Related]
12. Development of a herpes simplex virus subunit glycoprotein vaccine for prophylactic and therapeutic use. Burke RL Rev Infect Dis; 1991; 13 Suppl 11():S906-11. PubMed ID: 1664126 [TBL] [Abstract][Full Text] [Related]
13. Preparation and efficacy of an inactivated subunit vaccine (NFUIBHK) against type 2 Herpes simplex virus infection. Skinner GR; Williams DR; Buchan A; Whitney J; Harding M; Bodfish K Med Microbiol Immunol; 1978 Nov; 166(1-4):119-32. PubMed ID: 214676 [TBL] [Abstract][Full Text] [Related]
14. Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice. Cremer KJ; Mackett M; Wohlenberg C; Notkins AL; Moss B Science; 1985 May; 228(4700):737-40. PubMed ID: 2986288 [TBL] [Abstract][Full Text] [Related]
15. The effect of adjuvants on the efficacy of a recombinant herpes simplex virus glycoprotein vaccine. Sanchez-Pescador L; Burke RL; Ott G; Van Nest G J Immunol; 1988 Sep; 141(5):1720-7. PubMed ID: 2842401 [TBL] [Abstract][Full Text] [Related]
17. Restriction of latent herpes virus infection in rabbits immunized with subviral herpes simplex virus vaccine. Rajcáni J; Kutinová L; Vonka V Acta Virol; 1980 May; 24(3):183-93. PubMed ID: 6107035 [TBL] [Abstract][Full Text] [Related]
18. Vaccines for latent viruses. Pass F J Am Acad Dermatol; 1988 Jan; 18(1 Pt 2):224-6. PubMed ID: 2828442 [TBL] [Abstract][Full Text] [Related]
19. Protection and serum antibody responses in guinea-pigs and mice immunized with HSV-1 antigen preparations obtained using different detergents. Ertürk M; Welch MJ; Phillpotts RJ; Jennings R Vaccine; 1989 Oct; 7(5):431-6. PubMed ID: 2554607 [TBL] [Abstract][Full Text] [Related]
20. Adenovirus vectors as potential vaccines against herpes simplex virus. Johnson DC Rev Infect Dis; 1991; 13 Suppl 11():S912-6. PubMed ID: 1664127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]